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A number of cationic antimicrobial peptides, among which are
histatin 5 and the derived peptides dhvar4 and dhvar5, enter their
target cells and interact with internal organelles. There still are
questions about the mechanisms by which antimicrobial peptides
translocate across the membrane. We used a liposome model to
study membrane binding, translocation and membrane-perturbing
capacities of histatin 5, dhvar4 and dhvar5. Despite the differences
in amphipathic characters of these peptides, they bound equally
well to liposomes, whereas their membrane activities differed
remarkably: dhvar4 translocated at the fastest rate, followed by
dhvar5, whereas the histatin 5 translocation rate was much lower.
The same pattern was seen for the extent of calcein release: highest
with dhvar4, less with dhvar5 and almost none with histatin 5.
The translocation and disruptive actions of dhvar5 did not seem to
be coupled, because translocation occurred on a much longer time-
scale than calcein release, which ended within a few minutes. We
conclude that peptide translocation can occur through peptide–
phospholipid interactions, and that this is a possible mechanism
by which antimicrobial peptides enter cells. However, the trans-
location rate was much lower in this model membrane system
than that seen in yeast cells. Thus it is likely that, at least for some
peptides, additional features promoting the translocation across
biological membranes are involved as well.
Key words: antimicrobial peptide, histatin, liposome, LL-37,
membrane translocation.
INTRODUCTION
In the last few decades, an expansive number of antimicrobial pep-
tides have been isolated and characterized from virtually all
classes of organisms, where they play an important role in the
innate defence against microbial and viral infections. Character-
ization of these peptides has revealed a wide diversity in amino
acid sequences, yet with shared characteristic features: they are
usually polycationic and amphipathic, containing both a hydro-
philic and a hydrophobic side [1–3]. This promotes their binding
to and insertion into the cytoplasmic membrane of the target cell,
leading to perturbation of the membrane. Although membrane
lysis almost certainly is a key event in the bactericidal action of
many antimicrobial peptides, including temporins [4], catheli-
cidins [5–7] and mellitin [8,9], evidence has been produced
that, for a number of peptides, this is not the major mechanism
of action. For example, human salivary histatins and tenecin 3
have been shown to penetrate fungal pathogens to induce lethal
action intracellularly [10,11]. Also for other peptides, including
histatin derivatives [12] and lactoferricin B [13], uptake by their
target cells and killing apparently are obligatory linked processes.
Internalization of these antimicrobial peptides by target cells
share some features with uptake of basic peptides in mammalian
cells, e.g. the HIV-tat peptides, polyarginine and polylysine [14–
18]. Apparently, uptake does not require a distinct amino acid
sequence; nor is the chirality of the peptide backbone essential
[16,19]. On the other hand, an active metabolic condition for the
yeast or mammalian cell in many cases is a prerequisite for inter-
Abbreviations used: BAPNA, Nα-benzoyl-DL-arginine p-nitroanilide hydrochloride; CZE, capillary zone electrophoresis; Fmoc, fluoren-9-ylmethoxy-
carbonyl; PC, L-α-phosphatidylcholine; PS, 3-sn-phosphatidyl-L-serine; RP, reverse phase; SBTI, soya-bean trypsin inhibitor; TFA, trifluoroacetic acid.
1 To whom correspondence should be addressed (e-mail al.denhertog@vumc.nl).
nalization, since conditions and agents that diminish metabolism,
e.g. oxygen depletion or inhibition of respiration by sodium azide,
abrogated the translocation into the cell [10,15,20].
Although there is ample evidence that peptides translocate over
biological membranes, the internalization pathway is still a matter
of debate. The susceptibility to metabolic inhibitors has been
taken as evidence that active, endocytotic internalization pathways
are responsible for the uptake. On the other hand, it has been
argued that, since a specific primary structure is not essential,
internalization does not involve active endocytosis or specific pro-
tein transporters. Instead, a direct transport through the lipid
bilayer of the membrane, e.g. involving self-promoted uptake
via preformed peptide pores, has been suggested as a possible
mechanism of translocation [21,22]. Direct experimental evidence
in support of either mechanism, however, is scarce. In the present
study, we have addressed the question whether antimicrobial pep-
tides with different amphipathic features are able to diffuse pass-
ively through an artificial phospholipid bilayer. As model com-
pounds for antimicrobial peptides, we used histatin 5, a natural
antimicrobial peptide from human saliva, and two synthetic
variants derived from it, with enhanced and decreased amphi-
pathic features respectively [12,23]. Each of these peptides has
activity against yeast cells, and is internalized in these cells during
the killing process [12]. Translocation of peptides was examined
by monitoring peptide degradation by trypsin encapsulated
in PC/PS (L-α-phosphatidylcholine/3-sn-phosphatidyl-L-serine)
liposomes. To improve our understanding, the interaction with
the liposome membrane was characterized with regard to the
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amount of peptides bound to liposomes, the effect on the external
electrokinetic (zeta) potential of the phospholipid membrane, and
the disturbance of the membrane integrity.
EXPERIMENTAL
Peptide synthesis and purification
Histatin 5 (DSHAKRHHGYKRKFHEKHHSHRGY), dhvar4
(KRLFKKLLFSLRKY), dhvar5 (LLLFLLKKRKKRKY) and
the control peptides cysS1–13 (SSSKEENRIIPGG: the 13 N-ter-
minal amino acids of cystatin S) and LL-37 (LLGDFFRKSKE-
KIGKEFKRIVQRIKDFLRNLVPRTES: the human cathelicidin
antimicrobial peptide, which is strongly membrane active [24,25])
were synthesized by Fmoc (fluoren-9-ylmethoxycarbonyl) chem-
istry on a MilliGen 9050 peptide synthesizer (MilliGen/Bio-
search, Bedford, MA, U.S.A.) according to the manufacturer’s
procedures. N-α-Fmoc-protected amino acids and preloaded
PEG–PS [poly(ethylene glycol)–polystyrene] supports were
obtained from Applied Biosystems (Foster City, CA, U.S.A.).
Peptides were purified by preparative RP (reverse phase)-HPLC
on a Jasco HPLC System (Jasco Corporation, Tokyo, Japan) using
a VYDAC C18-column (218TP; 1.0 cm × 25 cm, 10 µm particles,
Hesperia, CA, U.S.A.), as described previously [26]. Briefly,
peptides were dissolved in 0.1% (v/v) TFA (trifluoroacetic acid)
and eluted with a linear gradient [from 15–60% (v/v) acetonitrile
containing 0.1% (v/v) TFA] in 20 min at a flow rate of 4 ml/min.
The absorbance of the column effluent was monitored at 214 nm,
and peak fractions were pooled, freeze-dried and reanalysed by
RP-HPLC using an analytic column, and also by CZE (capillary
zone electrophoresis; see below). The purity of the peptides was
at least 95%, and the authenticity of the peptides was confirmed
by ion-trap MS (mass spectrometry) on a LCQ Deca XP (Thermo
Finnigan, San Jose, CA, U.S.A.).
CZE
Purity and degradation of peptides was analysed by CZE on
a BioFocus 2000 Capillary Electrophoresis System (Bio-Rad,
Hercules, CA, U.S.A.) equipped with an uncoated fused silica
capillary of internal diameter 50 µm, and a length of 24 cm.
Samples were loaded by pressure injection at 20 lbf · in2 · s (where
1 lbf · in2 = 6.9 kPa), and peptide separation was performed
according to the manufacturer’s instructions at 10 kV (anode at
the detector side) and 20 ◦C using 0.1 M phosphate buffer, pH 2.5,
as the electrolyte. On-line UV detection was performed at 200 nm.
The running time of the analyses was 7 min, and data were
analysed using BioFocus Integrator software. Peptide degradation
was quantified by comparing the relevant peak heights with those
of the internal standard imidazole.
Liposome preparation
Unilamellar liposomes were prepared from a 9:1 (w/w) mixture
of egg-yolk PC and PS from bovine brain (Sigma–Aldrich,
St Louis, MO, U.S.A.). This liposome composition containing
negatively charged phospholipids (i.e. PS) was chosen as a model
for microbial membranes. The lipid mixture in chloroform was
vacuum-dried and hydrated in 1 ml of 10 mM Hepes buffer,
pH 7.2, to a final concentration of 2.5 mg/ml. After five cycles of
freeze-thawing, liposomes were extruded 21 times through two
stacked 400 nm filters, as described previously [27].
Calcein-loaded liposomes and trypsin-loaded liposomes were
prepared by hydration of the lipid mixture in 10 mM Hepes buffer,
pH 7.2, containing either 0.5 mM calcein or 100 µg/ml trypsin
(EC 3.4.21.4, sequencing grade; Roche Diagnostics GmbH,
Mannheim, Germany) and processed further, as described above.
Free calcein and trypsin were removed by centrifugation on a
Sephadex G-50 column, essentially as described previously [28].
Liposomes were stored at 4 ◦C and used within 48 h.
Zeta potential measurements
Effects of peptides on the zeta potential of liposomes were
examined as follows: dhvar4, dhvar5 or histatin 5, in concen-
trations ranging from 2.5 to 20 µM, were incubated for 5 min with
liposomes suspended in 10 mM Hepes, pH 7.2, at a lipid concen-
tration of 37.5 µg/ml. The zeta potentials derived from the electro-
phoretic mobilities of the liposome preparations were measured
on a DELSA 440 (Coulter Electronics, Inc., Hialeah, FL, U.S.A.),
which employs a four-angle detection of the Doppler shift of
frequency of scattered laser light. Data were analysed with the
accompanying analysis software (the DELSA 440SX control
program version 2.0.1) according to the manufacturer’s instruc-
tion manual, essentially as described previously [29].
Peptide binding to liposomes
Liposomes were suspended at 250 µg/ml lipid in Hepes buffer.
Binding (including uptake) was measured as the depletion of
peptides in supernatants of liposomes incubated for 15 min with
5–20 µM dhvar4, dhvar5, histatin 5 or cysS1–13. Samples were
centrifuged at 200 000 g at 4 ◦C for 30 min, and the concen-
trations of the remaining peptides in supernatants were measured
by CZE.
Peptide-induced liposome permeabilization
Calcein-loaded liposomes were used to measure peptide-induced
permeation of liposomes. To a suspension of calcein-loaded
liposomes (250 µg/ml lipid) in Hepes buffer, 40 µM dhvar4,
dhvar5 or histatin 5 was added. The changes in fluorescence in-
tensities were determined as a percentage of the maximal fluore-
scence intensity obtained after total lysis of the liposomes by
0.5% (v/v) Triton X-100. Calcein fluorescence was monitored
continuously over time at excitation and emission wavelengths of
494 nm and 520 nm respectively, on an SLM-Aminco SPF-500
fluorescence spectrometer. Because of an increase in turbidity of
the liposome suspension upon peptide addition, another method
was also used, in which the release of calcein was determined in
liposome supernatants. In this assay, the calcein-loaded liposomes
were centrifuged at 200 000 g for 30 min after a 15 min peptide
incubation, and the calcein fluorescence in the supernatant was
determined.
Determination of trypsin activity
Trypsin-loaded liposomes were suspended at a lipid concentration
of 250 µg/ml. The internal trypsin activity of trypsin-loaded lipo-
somes and the concentration of SBTI (soya-bean trypsin inhibitor)
required to block this activity was determined using FITC-
labelled gelatin (DQ-gelatin; Molecular Probes, Eugene, OR,
U.S.A.) as substrate. This substrate consists of highly quenched
FITC-labelled gelatin that, upon proteolytic digestion, releases
fluorescent fragments. Trypsin-loaded liposomes were lysed with
Triton X-100 and incubated with FITC-gelatin in Hepes buffer
supplemented with various concentrations of SBTI. Fluorescence
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Table 1 Sequences and characteristics of the peptides investigated
Data shown in the column labelled ‘Charge’ represent the total net charge based on the number of charged amino acids at pH 7. 〈µ〉 represents the mean hydrophobic moment of each respective
peptide in an α-helical conformation. LC50, peptide concentration (µM) at which 50 % of C. albicans cells are killed [12].
Mean hydrophobic
Peptide Sequence Mass (M r) Charge moment (〈µ〉) LC50 (µM)
Histatin 5 DSHAKRHHGYKRKFHEKHHSHRGY 3037.1 5+ 0.09 8.3
dhvar4* KRLFKKLLFSLRKY 1840.7 6+ 0.44 0.1
dhvar5 LLLFLLKKRKKRKY 1847.8 7+ 0.06 2.0
* This study includes dhvar4 (a more amphipathic variant derived from the active domain of histatin 5) and dhvar5 (a peptide in which the hydrophobic residues are concentrated in the N-terminal
part and the hydrophilic residues in the C-terminal part of the peptide).
was monitored in a fluorescence microplate reader (FLUOstar
Galaxy; BMG Laboratories GmbH, Offenburg, Germany) at ex-
citation and emission wavelengths of 485 nm and 520 nm respect-
ively. The capacity of 20 µg/ml SBTI to inhibit all trypsin in
the samples was confirmed by incubation of 40 µM peptides
with 1 µg/ml trypsin or lysed trypsin-loaded liposomes in the
presence of 20 µg/ml SBTI. After different time intervals,
aliquots were taken and analysed by CZE, revealing that the
peptides were not degraded, and confirming that the SBTI con-
centration was high enough to effectively inhibit all trypsin.
Liposome-bound peptide degradation
To study whether liposome-bound peptides were susceptible to
degradation, 10 µM peptides were incubated in Hepes buffer
with liposomes at 250 µg/ml lipid, with addition of 10 µg/ml
imidazole. After 15 min of incubation, binding of the peptides
to the liposomes was determined as described above. Thereafter,
1 µg/ml trypsin was added to the liposome/peptide mixture and
degradation was followed in time by CZE. As a reference, peptides
were incubated with trypsin in buffer without liposomes.
Degradation of peptides by trypsin-loaded liposomes
Trypsin-loaded liposomes were suspended in Hepes buffer sup-
plemented with 20 µg/ml SBTI and 10 µg/ml imidazole, as an
internal standard for CZE, at a lipid concentration of 250 µg/ml.
The concentration of SBTI was sufficient to effectively inhibit all
trypsin activity after liposomes were lysed with 0.1% (v/v) Triton
X-100. The suspension was subsequently incubated with 40 µM
each of histatin 5, dhvar4, dhvar5 or cysS1–13. After several time
intervals, 50 µl aliquots were taken, boiled for 5 min to inhibit
all trypsin activity, lysed in 0.1% Triton X-100 and analysed by
CZE. Degradation of peptide implied digestion of the internalized
peptide by the trypsin within the liposomes.
Furthermore, trypsin-loaded liposomes were incubated with
peptides in the absence of SBTI to study peptide-induced leakage
of trypsin, and peptide degradation due to this leakage. After
these peptide incubations, the liposomes were centrifuged, and the
trypsin activity was measured in the supernatants in a colorimetric
assay.
Peptide-induced trypsin leakage from liposomes
Trypsin-loaded liposomes were incubated for 15 min with 40 µM
peptides and centrifuged at 200000 g at 4 ◦C for 30 min. Aliquots
(90 µl) of the supernatants were mixed with 10 µl of 10 mM
BAPNA (Nα-benzoyl-DL-arginine p-nitroanilide hydrochloride;
Sigma–Aldrich) in 200 mM Tris/HCl, pH 9, containing 10 mM
CaCl2. After 30 min of incubation at 37 ◦C, colour development
was measured at 405 nm.
RESULTS
A number of cationic antimicrobial peptides, including histatin 5
and designed variants derived from its active domain, are able to
translocate across the cell membrane of their target organisms.
However, it is unknown whether these peptides diffuse passively
over the membrane, or are actively taken up via transport proteins.
In the present study, the membrane-translocating properties
of histatin 5 and derived peptides (Table 1) were examined
and compared with their membrane-binding and membrane-dis-
rupting activities using unilamellar liposomes as a model system
for phospholipid membranes. All experiments were repeated at
least three times, yielding identical results.
Peptide translocation
To investigate the membrane translocation of peptides, an enzyme
digestion assay was developed in which peptides were incubated
with trypsin-loaded liposomes. It was verified that all peptides
used were susceptible to trypsin, and that peptide binding to
liposomes did only slightly decrease the degradation by trypsin.
This is shown for dhvar4 and dhvar5 (Figure 1). Precautions were
taken to prevent degradation by any free trypsin by performing
the incubations in the presence of the trypsin inhibitor SBTI (at
a concentration of 20 µg/ml, which was sufficient to completely
inhibit any external trypsin activity). Thus peptide degradation by
trypsin was taken to imply that translocation over the liposome
membrane had occurred. A second experiment was performed in
the absence of SBTI to study the capacity of peptides to cause
trypsin leakage.
Histatin 5, dhvar4 and dhvar5 were incubated with trypsin-
loaded liposomes in the presence or absence of 20 µg/ml SBTI.
At several time points aliquots were taken, boiled to inactivate
the trypsin and then analysed by CZE (Figure 2A). The extent of
degradation was quantified in the electropherogram by measuring
the peptide peak height of the sample and comparing it with the
initial peptide peak height (Figure 2B). Both in the presence and
absence of SBTI, the rate of degradation was highest for dhvar4,
less for dhvar5, whereas histatin 5 was hardly degraded. Within
5 min, the dhvar4 peak had decreased by 40%. Concomitantly, in
the electropherogram a number of novel peaks appeared, demon-
strating the formation of dhvar4 degradation products. After 2 h
incubation, dhvar4 was virtually completely degraded, and the
number and height of the peaks corresponding to degradation
products had increased further. At a 10-fold-lower dhvar4/lipid
ratio, degradation also occurred within 5 min (results not shown).
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Figure 1 Liposome-bound peptide degradation
Unloaded liposomes were incubated with 10 µM dhvar4 (A) or dhvar5 (B) and incubated for
15 min. Trypsin (1 µg/ml) was added, and degradation was measured by CZE after 5, 30, 60
and 120 min () and compared with degradation of peptides without liposomes ().
Dhvar5 was degraded more slowly than dhvar4, exhibiting little
degradation after 5 min of incubation, and only 40% after
2 h. Histatin 5 was only slightly degraded within 2 h. After 24 h,
approx. 50% of the histatin 5 peak had disappeared (results not
shown).
As control peptides, LL-37, known to have strong membrane
effects, and the inactive cysS1–13 were included. cysS1–13 was
only slightly degraded in both types of experiments, indicating
that the external amount of trypsin was negligible. Strikingly,
LL-37 was not degraded in the presence of SBTI, but was directly
and completely degraded in the absence of SBTI, indicating dis-
ruption of the membrane integrity. This was supported further
by the high trypsin activity found outside the liposomes after in-
cubation with LL-37 (Figure 3). Thus, in contrast with the other
peptides, the damage caused by LL-37 made the liposomes perme-
able for molecules as large as trypsin or SBTI.
Peptide binding to liposomes
To examine whether the low translocation observed with histatin 5
and dhvar5 was caused by differences in lipid avidity of the various
peptides, association of peptides with (unloaded) liposomes was
studied by measuring the depletion of peptides from liposome
supernatants after incubation (Figure 4). All peptides displayed a
comparable dose–response behaviour in the concentration range
tested. Binding reached saturation at a peptide concentration of
approx. 10 µM. Despite the similarity in charge and size, the pep-
tides had very different effects on the zeta potential of the peptide–
liposome complexes formed (Figure 5). An increase in zeta
potential of the liposomes from −50 mV to −10 mV was induced
by histatin 5, and a zeta potential of 0 mV was obtained by
incubation with dhvar4. Upon incubation with dhvar5, the zeta
potential of the liposomes became positive at concentrations
above 5 µM, and reached a maximal value of +20 mV at con-
centrations above 20 µM. Since dhvar5 possesses just one more
positive charge than dhvar4, this suggests that these peptides insert
differently into the liposome surface.
Peptide-induced liposome permeabilization
The effect of peptides on the integrity of liposomes was studied
using calcein-loaded liposomes. The release of calcein was me-
asured as the ‘dequenching’ of the calcein fluorescence and moni-
tored continuously. Total (100%) calcein release was determined
as the fluorescence signal after addition of 0.1% Triton X-100
to the liposome suspension (Figure 6A). Directly after peptide
addition, a decrease in fluorescence was observed, immediately
followed by an increase in fluorescence, which was maximally
30% for dhvar4 and happened within 2 min. Histatin 5 and dhvar5
only marginally increased calcein fluorescence. We noted that
the initial decreases in fluorescence were due to an increase in
turbidity of the samples. As the turbidity persisted throughout
the measurements, all fluorescence levels were underestimated.
Therefore an alternative method was used, in which, after
15 min of incubation, the calcein fluorescence was determined
in the supernatants, obtained by centrifugation of the liposomes
(Figure 6B). We found the same pattern in membrane-disrupting
properties as in the continuous measurements; however, the
increases in fluorescence were substantially higher, being 100%
for 20 µM dhvar4, 70% for 20 µM dhvar5 and 10% for 20 µM
histatin 5 respectively. The control peptide cysS1–13 induced no
release at all.
DISCUSSION
Antimicrobial peptides are able to interact with, and insert into,
negatively charged cytoplasmic membranes of their target cells
due to the presence of spatially segregated hydrophobic and
cationic domains. The microbial specificity of cationic antimicro-
bial peptides has been ascribed to the fact that microbial mem-
branes contain more negatively charged phospholipids than host
membranes. The peptide–membrane interaction is thought to
interfere with the barrier function of the membrane, resulting in
killing of the target cells. Indeed, there is a considerable body of
data indicating that such peptides cause leakage in model mem-
brane systems, as well as in bacteria and yeast cells. Hence several
membrane-permeabilization mechanisms have been proposed
[1,30–32]. Although these mechanisms differ with regard to the
precise molecular events involved, in each of these the formation
of peptide–membrane complexes is assumed. Strikingly, studies
addressing the localization of antimicrobial peptides in their target
cells indicate that, in most cases, these are internalized, implying
transmembrane migration, rather than remaining associated with
the cytoplasmic membrane of their target cells [30]. This has
been demonstrated not only for widely different natural, as well
as artificial, antimicrobial peptides [10–13,33,34], but also for
homopolymers [16]. In fact, only for a few cationic peptides has
stable binding to the plasma membrane of their target cell been
demonstrated unequivocally [6,35].
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Figure 2 Detection of peptide translocation into liposomes using the enzymic digestion assay
(A) Trypsin-loaded liposomes (250 µg/ml) were incubated with 40 µM peptides. At the zero time point (left column) and after 120 min, aliquots were taken, boiled for 5 min, and lysed with 0.1 %
Triton X-100. Incubations were carried out either in the presence (middle column) or absence (right column) of SBTI. Samples were analysed by CZE using imidazole as internal standard (IS). Histatin 5
(panel 1) showed virtually no translocation into the liposomes within 2 h (panel 2). Dhvar4 (panel 4) translocated completely within 2 h (panel 5), whereas dhvar5 (panel 7) translocation was
intermediate. A substantial part of the dhvar5 peak remained after 2 h incubation (panel 8). LL-37 (panel 10) apparently showed no translocation (panel 11), although it has well-known membrane
activity. In the incubations without SBTI, LL-37 was completely degraded (panel 12), indicating that this peptide rapidly caused severe membrane damage, enabling inactivation of trypsin by SBTI
in an early stage of the experiment. In this experiment, the other peptides showed CZE profiles similar to those in the experiment with SBTI, indicating that these peptides do not cause such severe
membrane damage as LL-37, and demonstrating that the low degradation of histatin 5 truly represents its low ability to translocate over the lipid membrane. (B) Kinetics of the peptide translocation
into liposomes in the presence of 20 µg/ml SBTI. Histatin 5 () showed almost no translocation into liposomes, dhvar5 () showed intermediate translocation, whereas dhvar4 () showed almost
complete degradation within 2 h.
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Figure 3 Peptide-induced trypsin leakage from liposomes
Trypsin-loaded liposomes were incubated for 15 min with 40 µM peptides. Liposomes were
centrifuged, and trypsin activity was determined in the supernatants using the chromogenic
substrate BAPNA (1 mM). After a 30 min incubation at 37 ◦C, colour development was measured
at 405 nm. LL-37 was the only peptide to cause massive efflux of trypsin from the liposomes.
Figure 4 Peptide binding to liposomes
Liposomes were incubated for 15 min with 5, 10 or 20 µM histatin 5 (), dhvar4 () or dhvar5
() and centrifuged for 30 min at 200 000 g. Peptide binding to liposomes was determined
by CZE by comparing the peak heights of the supernatants with those of the initial peptide
concentration in running buffer. All three peptides showed a maximal binding of +− 10 µM,
achieved within 15 min.
Figure 5 Zeta potential of liposomes incubated with peptides
Zeta potential of liposomes was measured as a function of the peptide concentration (37.5 µg/ml
liposomes; 5 min of incubation). All peptides caused a rise in zeta potential. dhvar4 (20 µM;
) completely neutralized the negative charge of the liposomes, whereas dhvar5 () even led
to a positive zeta potential of 20 mV. Histatin 5 () showed the least neutralizing activity.
Figure 6 Peptide-induced calcein release from liposomes
(A) Calcein-loaded liposomes were incubated with 20 µM peptides. The increase in
fluorescence, caused by dequenching of the calcein upon release from the liposomes, was
monitored continuously over time. Triton X-100 (0.1 %) was added to liposomes to determine
the maximal increase in fluorescence. Upon addition of the peptides, the turbidity of the
suspension increased, which interfered with the fluorescence signal. Note the decrease in
fluorescence upon dhvar5 addition (shown by the asterisk) caused by this phenomenon. (B) To
obviate this interference, the peptide/liposome incubation mixtures were centrifuged, and the
calcein fluorescence in the supernatants was measured. Histatin 5 () induced little, if
any calcein release, dhvar5 () induced 70 % release, and dhvar4 () caused 100 % release.
For both dhvar4 and dhvar5, maximal calcein release was obtained at 5 µM.
In the present study, we used a liposome model to address the
question of whether spontaneous diffusion over a phospholipid
double layer is feasible for histatin 5, dhvar4 and dhvar5. These
peptides differ in fungicidal potency (Table 1), but all translocate
over the plasma membrane of their target cells [36]. There is some
debate on the translocation mechanism involved, i.e. whether an
active endocytotic pathway is involved or whether translocation
occurs via passive diffusion; the internalization of these peptides
is sensitive to metabolic inhibitors, although an all-D variant of
a histatin fragment was equally well internalized [19,37,38], ex-
cluding the involvement of a stereospecific receptor.
We used liposomes, composed of PC and PS, as a simplified
model for the microbial membrane. Peptide translocation was
studied over phospholipid bilayers by monitoring their degra-
dation by trypsin entrapped in liposomes. To prevent peptide
degradation by external trypsin, incubations were carried out in
the presence of a trypsin inhibitor (SBTI). It should be pointed out
that large membrane defects, allowing influx of inhibitor or efflux
of trypsin, result in instantaneous neutralization of trypsin activity,
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which erroneously may be interpreted as lack of membrane
translocation. For instance, the cathelicidin LL-37, which induces
sufficiently large membrane defects to allow efflux of trypsin
(Figure 3), was not degraded in the presence of the externally
added SBTI (Figure 2A, panel 11). Since translocation in this
system involves various steps, namely association, translocation
and trypsin degradation, it is necessary to identify the rate-limiting
step. We found that the binding of peptides to the liposomes
was completed within 15 min (results not shown), excluding
the possibility that this step was rate-limiting. Neither was
trypsin degradation of (liposome-bound) peptides rate-limiting:
liposome-bound dhvar4 and dhvar5 were readily degraded [half-
life (t1/2 ) 5 min; Figure 1], even at a trypsin concentration
100 times lower than in the trypsin-loaded liposomes. In contrast,
degradation of peptides by trypsin-loaded liposomes occurred
much more slowly (t1/2 of 20 min and >2 h for dhvar4 and dhvar5
respectively). We therefore conclude that translocation of peptide
from the outer to the inner leaflet represents the rate-limiting step.
We established that passive diffusion over liposome mem-
branes, without the involvement of transporters, was possible, but
found large differences in translocation rates. The amphipathic
peptide dhvar4 translocated fastest over the phospholipid double
layer, followed by dhvar5, and then histatin 5, which was hardly
translocated. The same ranking order was also found for the
amount of peptide-induced calcein release, which reflects the abi-
lity of peptides to induce small defects in the phospholipid double
layer (Figure 6). The calcein release occurred much faster than
the translocation, e.g. whereas dhvar4-induced calcein release
was essentially completed within 2 min, after 5 min only 40%
of dhvar4 had translocated over the membrane. Furthermore,
dhvar5 caused maximally 60% calcein release, in a process that
essentially was completed within 2 min. At this time-point little,
if any, degradation of dhvar5 by trypsin-loaded liposomes had
occurred (Figure 2B). This suggests that the actions of dhvar5
differ from the pore-forming model, in which pore forming and
translocation are coupled processes [31]. This may be due to the
structure of dhvar5, which exhibits ‘head-to-tail’ amphipathicity,
with all positive residues concentrated in the C-terminal domain
of the peptide and the hydrophobic residues in the N-terminal
domain, as opposed to the laterally amphipathic peptides, such as
dhvar4.
Histatin 5, dhvar4 and dhvar5 exhibited similar binding to lipo-
somes, both with regard to the number of molecules bound and the
rate of binding, which was completed within 15 min (Figure 4).
However, analysis of the electrostatic properties of the liposome
surface by zeta potential measurement, after incubation with the
peptides, revealed interesting differences (Figure 5). Liposomes
saturated with dhvar4 exhibited a nearly neutral zeta potential,
whereas that of dhvar5-saturated liposomes was +20 mV. This
can be explained on basis of the different structural features of
these peptides: the segregation in hydrophilic and hydrophobic
domains promotes a perpendicular orientation of dhvar5 mole-
cules in the phospholipid double layer, with its hydrophobic
domain inserted into the core of the double layer, and the positively
charged residues exposed at the surface, possibly protruding into
solution. On the other hand, in dhvar4 the cationic residues are
evenly distributed over the peptide, but the peptide can form an
α-helix with lateral amphipathicity. It is assumed that, upon initial
interaction with the membrane, dhvar4 and similar peptides adopt
an amphipathic α-helical structure that is oriented parallel to the
membrane, with the cationic side of the helix electrostatically
bound to the negatively charged head groups of phospholipids
[39].
Artificial membranes and liposomes are generally considered
as a paradigm for biological membranes, in order to study the
mechanism of action of antimicrobial peptides. There is no
doubt that, with this approach, valuable insight has been gained
into the molecular forces that control the interaction between
amphipathic peptides and phospholipid bilayers. We show that
the used peptides are able to translocate over a phospholipid bi-
layer and may enter cells without intervention of an (active) mem-
brane-transport system. However, in line with previous reports,
the present study shows that any kind of membrane activity of a
peptide measured in the liposome model system does not neces-
sarily occur to the same extent in biological systems [40,41].
This is illustrated best for histatin 5, which exhibits low, if any,
membrane activity in the model system, whereas this peptide
exhibits a number of membrane-related activities against bacteria
and fungi. For instance, antimicrobial activity of histatin 5 is
coupled with translocation over the membrane of the target cells,
as well as with disruption of the membrane. The latter is high-
lighted by efflux of ions and nucleotides, dissipation of trans-
membrane gradients and influx of propidium iodide [10,12,42–
44]. Strikingly, histatin 5 has not been located at the cytoplasmic
membrane of its target cells [10,12,36], contrary to what would
be expected from the liposome studies. Essentially similar ob-
servations have been made for dhvar4 and dhvar5, which exhibit
membrane activities in biological systems that are faster and more
pronounced than in liposomes. This points to the involvement of
additional features promoting the lipid translocation of peptides
across biological membranes. For instance, it is conceivable that
a negative-inside potential over the membrane of a living cell
will act as a driving force, accelerating translocation of cationic
peptides. Indeed, application of an artificial membrane potential in
liposomes leads to enhanced transmigration [45–47]. In addition,
biological membranes contain proteins or specific lipids that may
function as primary receptors for this type of peptides, thereby
facilitating their entry into the cell. It has been claimed that entry
of histatin 5 into Candida albicans is mediated by a receptor
protein in the cell wall, identified as the heat-shock protein
Ssa1p [48,49]. On the basis of the present data we conclude
that classical amphipathic peptides like dhvar4 can enter their
target cells by passive diffusion, driven by the peptide gradient,
over the phospholipid bilayer, with concomitant formation of
temporary pores. In contrast, cell entry of peptides with a less
pronounced amphipathic character, such as histatin 5, requires
additional involvement of intrinsic membrane features.
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